KBIO LABS Inc. (KOSDAQ:038530)
South Korea · Delayed Price · Currency is KRW 1,020.00
+59.00 (6.14%)
At close: Aug 24, 2026
KBIO LABS Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 26,364 | 27,835 | 25,409 | 32,455 | 36,903 | 107,381 | |
Market Cap Growth | -15.46% | 9.54% | -21.71% | -12.05% | -65.63% | 343.52% |
Enterprise Value | 13,092 | 24,513 | 39,130 | 31,170 | -10,767 | 105,587 |
Last Close Price | 1020.00 | 1205.00 | 1100.00 | 1405.00 | 2010.00 | 6450.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 0.32 | 0.32 | 0.33 | 1.19 | 1.19 | 12.31 |
PB Ratio | 0.25 | 0.27 | 0.24 | 0.25 | 0.55 | 1.71 |
P/TBV Ratio | 0.50 | 0.54 | 0.45 | 0.54 | 0.59 | 1.83 |
P/FCF Ratio | 3.33 | 3.41 | - | - | 9.79 | - |
P/OCF Ratio | 3.32 | 3.40 | - | - | 9.75 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.16 | 0.28 | 0.51 | 1.14 | - | 12.11 |
EV/EBITDA Ratio | 23.19 | 14.48 | - | - | - | - |
EV/EBIT Ratio | - | 32.44 | - | - | - | - |
EV/FCF Ratio | 1.66 | 3.00 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.03 | 0.16 | 0.31 |
Debt / EBITDA Ratio | 1.44 | 0.35 | - | - | 10.11 | - |
Debt / FCF Ratio | 0.10 | 0.07 | - | - | 2.80 | - |
Net Debt / Equity Ratio | -0.61 | -0.63 | -0.48 | -0.42 | -0.52 | -0.59 |
Net Debt / EBITDA Ratio | -113.23 | -38.30 | 1995.55 | 424.66 | -33.08 | 8.49 |
Net Debt / FCF Ratio | -8.08 | -7.95 | 271.76 | 36.30 | -9.17 | 30.90 |
Asset Turnover | 0.69 | 0.74 | 0.59 | 0.24 | 0.37 | - |
Inventory Turnover | 12.07 | 13.65 | 15.21 | 7.94 | 10.51 | - |
Quick Ratio | 5.02 | 4.62 | 6.28 | 5.33 | 3.09 | 2.53 |
Current Ratio | 5.84 | 5.20 | 7.35 | 6.11 | 3.27 | 2.67 |
Return on Equity (ROE) | -2.63% | -4.82% | -8.49% | -12.11% | -10.81% | - |
Return on Assets (ROA) | -0.20% | 0.40% | -0.53% | -0.34% | 0.33% | - |
Return on Capital Employed (ROCE) | -0.40% | 0.70% | -1.00% | -0.50% | 0.70% | -8.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -8.88% | -11.49% | -26.73% | -39.05% | -20.77% | -18.13% |
FCF Yield | 30.00% | 29.32% | -0.75% | -4.53% | 10.21% | -1.13% |
Buyback Yield / Dilution | 0.05% | - | -13.03% | -12.29% | -17.81% | -737.44% |